These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1737562)

  • 1. [Amylin--a newly identified pancreatic peptide and its relationship to diabetes mellitus].
    Storch MJ; Kerp L
    Dtsch Med Wochenschr; 1992 Feb; 117(7):267-71. PubMed ID: 1737562
    [No Abstract]   [Full Text] [Related]  

  • 2. [Amylin: its potential role in the etiopathogenicity of diabetes mellitus].
    Artozqui Morrás E; Botella Serrano M; Camblor M; Bretón Lesmes I; Moreno Esteban B
    An Med Interna; 1993 Apr; 10(4):200-2. PubMed ID: 8513090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Islet amyloid polypeptide or amylin; breakthrough in the diagnosis and prevention of type II diabetes mellitus?].
    Lips CJ; Höppener JW; Erkelens DW
    Ned Tijdschr Geneeskd; 1993 Apr; 137(15):754-7. PubMed ID: 8479567
    [No Abstract]   [Full Text] [Related]  

  • 4. Copper-mediated formation of hydrogen peroxide from the amylin peptide: a novel mechanism for degeneration of islet cells in type-2 diabetes mellitus?
    Masad A; Hayes L; Tabner BJ; Turnbull S; Cooper LJ; Fullwood NJ; German MJ; Kametani F; El-Agnaf OM; Allsop D
    FEBS Lett; 2007 Jul; 581(18):3489-93. PubMed ID: 17617411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide.
    Green JD; Kreplak L; Goldsbury C; Li Blatter X; Stolz M; Cooper GS; Seelig A; Kistler J; Aebi U
    J Mol Biol; 2004 Sep; 342(3):877-87. PubMed ID: 15342243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin.
    Nilsson MR; Raleigh DP
    J Mol Biol; 1999 Dec; 294(5):1375-85. PubMed ID: 10600392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus.
    Cho WJ; Jena BP; Jeremic AM
    Methods Cell Biol; 2008; 90():267-86. PubMed ID: 19195555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological action of pancreatic amylin: relationship with glucose metabolism, diabetes, obesity and calcium metabolism.
    Koopmans SJ; Radder JK; Krans HM; Barge RM
    Neth J Med; 1992 Aug; 41(1-2):82-90. PubMed ID: 1407245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "A" is for amylin and amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2001 Jul; 2(4):124-39. PubMed ID: 11875249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet amyloid polypeptide/amylin contents in pancreata increase in genetically obese and diabetic mice.
    Tokuyama Y; Kanatsuka A; Yamaguchi T; Ohsawa H; Makino H; Nishimura M; Yoshida S
    Horm Metab Res; 1993 Jun; 25(6):289-91. PubMed ID: 8344641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.
    Lorenzo A; Razzaboni B; Weir GC; Yankner BA
    Nature; 1994 Apr; 368(6473):756-60. PubMed ID: 8152488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of amylin in the physiologic and physiopathologic regulation of energy metabolism].
    Cooper GJ
    Journ Annu Diabetol Hotel Dieu; 1991; ():125-39. PubMed ID: 1886326
    [No Abstract]   [Full Text] [Related]  

  • 15. [A novel hormone in islet of pancreas--islet amyloid polypeptide].
    Wu SQ
    Sheng Li Ke Xue Jin Zhan; 1992 Jul; 23(3):260-3. PubMed ID: 1299966
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.
    Aitken JF; Loomes KM; Konarkowska B; Cooper GJ
    Biochem J; 2003 Sep; 374(Pt 3):779-84. PubMed ID: 12812521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human but not rat amylin shares neurotoxic properties with Abeta42 in long-term hippocampal and cortical cultures.
    Lim YA; Ittner LM; Lim YL; Götz J
    FEBS Lett; 2008 Jun; 582(15):2188-94. PubMed ID: 18486611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue expression and secretion of amylin.
    Young A
    Adv Pharmacol; 2005; 52():19-45. PubMed ID: 16492539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications.
    Roth JD; Maier H; Chen S; Roland BL
    Arch Neurol; 2009 Mar; 66(3):306-10. PubMed ID: 19273748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin is a kinetic but not a thermodynamic inhibitor of amylin aggregation.
    Cui W; Ma JW; Lei P; Wu WH; Yu YP; Xiang Y; Tong AJ; Zhao YF; Li YM
    FEBS J; 2009 Jun; 276(12):3365-71. PubMed ID: 19438709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.